Alex Freeman

602 citations
10 papers · 226 indexed · h-index 6

Impact in

Papers in

    • Urologic and reproductive health conditions 4
    • Bone Tumor Diagnosis and Treatments 2

Alex Freeman

9 papers receiving 216 citations

Peers

Alex Freeman
Comparison fields: 5 of 49
  • Pathology and Forensic Medicine 60
  • Cancer Research 45
  • Oncology 81
  • Urology 11
  • Otorhinolaryngology 7
Replace Hongbo Sun with:
Hongbo Sun China
Mayuko Inuzuka Japan
Hy-Sook Kim South Korea
M K Heatley United Kingdom
Susan Valmadre Australia
Carmen Mir Spain
Seiji Yunotani Japan
Shengliang Shi China
S. Ushigome Japan
René Scheiden Luxembourg
Alex Freeman relative to Hongbo Sun China Hongbo Sun's profile →
Citations per field
00.5×3.7×
Hongbo Sun · 1×
Citations per year

Countries citing papers authored by Alex Freeman

Since Specialization
Citations

This map shows the geographic impact of Alex Freeman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alex Freeman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alex Freeman more than expected).

Fields of papers citing papers by Alex Freeman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alex Freeman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alex Freeman. The network helps show where Alex Freeman may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Alex Freeman, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Alex Freeman Line = papers co-authored together Alex Freeman links everyone, so they are left out of the graph.

All Works

10 of 10 papers shown
#Work
1 20151
2 201426
3 200928
4 20093
5 20091
6 200710
7 200412
8 20030
9 200311
10 2002134

About Alex Freeman

Alex Freeman is a scholar working on Rheumatology, Urology, Pulmonary and Respiratory Medicine, Small Animals and Dermatology, having authored 10 papers that have together received 226 indexed citations. Recurring topics across this work include Urologic and reproductive health conditions (4 papers), Prostate Cancer Diagnosis and Treatment (3 papers), Genital Health and Disease (3 papers), Sarcoma Diagnosis and Treatment (2 papers), Bone Tumor Diagnosis and Treatments (2 papers), Veterinary Medicine and Surgery (1 paper), Urinary and Genital Oncology Studies (1 paper) and Genetic and Kidney Cyst Diseases (1 paper). The work is most often cited by research in Pathology and Forensic Medicine (60 citations), Cancer Research (45 citations), Oncology (81 citations), Urology (11 citations) and Otorhinolaryngology (7 citations). Alex Freeman has collaborated with scholars based in United Kingdom, Malaysia and Portugal. Frequent co-authors include Lesley S. Morris, Nicholas Coleman, Ronald A. Laskey, R J Davies, Sheila Bingham, S. J. Dilworth, Richard N. Miller, Ian Scott, Jorge S. Reis‐Filho and Gareth Williams. Their work appears in journals such as Modern Pathology, Archives of Pathology & Laboratory Medicine, Clinical Cancer Research, Journal of Clinical Oncology and The Journal of Urology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026